1 enrolling by invitation. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Chorea: new trials by email Literature Review of Chorea trials Research Report on Chorea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Extension of SKY-0515 in Participants With Huntington's Disease SKY-0515 - Huntington's Disease (HD) | Phase 2 / Phase 3 | Enrolling by invitation | Skyhawk Therapeutics, Inc. | 500 | 2026-04-10 | 2026-07-24 |
Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dementia (1) · Dyskinesias (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Mental Disorders (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1)
Skyhawk Therapeutics, Inc. (1)
Australia (1) · New Zealand (1)